Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. 1940.
Rev Infect Dis. 1988 Jul-Aug;10(4):677-8.
Acar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin
Infect Dis. 1997 Jan;24 Suppl 1:S17-8.
Acolet D, Ahmet Z, Houang E, Hurley R, Kaufmann ME. Enterobacter cloacae in a
neonatal intensive care unit: account of an outbreak and its relationship to use
of third generation cephalosporins. J Hosp Infect. 1994 Dec;28(4):273-86.
Aftab R, Iqbal I. Bacteriological agents of neonatal sepsis in NICU at Nishtar
Hospital Multan. J Coll Physicians Surg Pak. 2006 Mar;16(3):216-9.
Ahmed AS, Chowdhury MA, Hoque M, Darmstadt GL. Clinical and bacteriological
profile of neonatal septicemia in a tertiary level pediatric hospital in
Bangladesh. Indian Pediatr. 2002 Nov;39(11):1034-9.
Ako-Nai AK, Adejuyigbe EA, Ajayi FM, Onipede AO. The bacteriology of neonatal
septicaemia in Ile-Ife, Nigeria. J Trop Pediatr. 1999 Jun;45(3):146-51.
Akova M, Yang Y, Livermore DM. Interactions of tazobactam and clavulanate with
inducibly- and constitutively-expressed Class I beta-lactamases. J Antimicrob
Chemother. 1990 Feb;25(2):199-208.
Alarcon A, Peña P, Salas S, Sancha M, Omeñaca F. Neonatal early onset Escherichia
coli sepsis: trends in incidence and antimicrobial resistance in the era of
intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J. 2004
Apr;23(4):295-9.
Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-
mediated AmpC beta-lactamases in the United States. Antimicrob Agents
Chemother. 2004 Feb;48(2):533-7.
Ambe JP, Gasi IS, Mava Y. Review of neonatal infections in University of
Maiduguri Teaching Hospital: common bacterial pathogens seen. Niger J Clin
Pract.2007 Dec;10(4):290-3.
Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci.
1980 May 16;289(1036):321-31 AmpC-producing Escherichia coli clinical
isolates recovered in a French hospital.J Antimicrob Chemother. 2008
Mar;61(3):498-503.
Amstey MS, Lewin E, Colaice J. Vaginal colonization with invasive Escherichia coli
during pregnancy. Am J Obstet Gynecol. 1980 Jul 1;137(5):534-5.
Andrea L. Shane . Estimating the National Burden of Neonatal Early Onset Sepsis
(M.D. Thesis), Faculty of the Graduate School of Emory University. 2009.
138
Antia-Obong OE, Utsalo SJ, Udo JJ, Udo KT. Neonatal septicaemia in Calabar,
Nigeria. Cent Afr J Med. 1992 Apr;38(4):161-5 antimicrobial resistance with
beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of
Acinetobacter baumannii endemic to New York City. Antimicrob Agents
Chemother. 2008 Sep;52(9):2999-3005.
Arora S, Bal M. AmpC beta-lactamase producing bacterial isolates from Kolkata
hospital. Indian J Med Res. 2005 Sep;122(3):224-33.
Asay LD, Koch R. Pseudomonas infections in infants and children. N Engl J Med.
1960 May 26;262:1062-6.
Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman
J.Intravenous lipid emulsions are the major determinant of coagulase-negative
staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect
Dis J. 1998 Jan;17(1):10-7.
Ayengar V, Madhulika, Vani SN. Neonatal sepsis due to vertical transmission from
maternal genital tract. Indian J Pediatr. 1991 Sep-Oct;58(5):661-4.
Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp.
collected from intensive care units in Southern and Western Europe in 1997-
1998. J Antimicrob Chemother. 2000 Feb;45(2):183-9.
Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of
Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility
pattern in a tertiary care hospital. Indian J Med Microbiol. 2004 Jul-
Sep;22(3):172-4.
Bagattini M, Crivaro V, Di Popolo A, Gentile F, Scarcella A, Triassi M, Villari P,
Zarrilli R. Molecular epidemiology of extended-spectrum beta-lactamase-
producing Klebsiella pneumoniae in a neonatal intensive care unit. J
Antimicrob Chemother. 2006 May;57(5):979-82.
Baker CJ, Barrett FF. Transmission of group B streptococci among parturient women
and their neonates. J Pediatr. 1973 Dec;83(6):919-25
Balaka B, Agbèrè AD, Baeta S, Kessie K, Assimadi K. [Bacterial flora in the genital
tract the last trimester of pregnancy]. J Gynecol Obstet Biol Reprod (Paris).
2003 Oct;32(6):555-61.
Bang AT, Paul VK, Reddy HM, Baitule SB. Why do neonates die in rural
Gadchiroli, India? (Part I): primary causes of death assigned by neonatologist
based on prospectively observed records. J Perinatol. 2005 Mar;25 Suppl
1:S29-34.
Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-
hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland.
J Antimicrob Chemother. 2002 Sep;50(3):393-6.
139
Barlow M, Hall BG. Origin and evolution of the AmpC beta-lactamases of
Citrobacter freundii. Antimicrob Agents Chemother. 2002 May;46(5):1190-8.
Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrange PH, Philippon A. Salmonella
enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with
an ampR gene from Morganella morganii. Antimicrob Agents Chemother.
1998 Sep;42(9):2352-8.
Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold
P,Röhnisch T, Schweighart S, Wilhelm R. A new plasmidic cefotaximase from
patients infected with Salmonella typhimurium. Infection. 1992 May-
Jun;20(3):158-63.
Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC beta-lactamases: how far
have we gone 10 years after the discovery? Yonsei Med J. 1998
Dec;39(6):520-5.Review
Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a
clinical isolate of Escherichia coli. Infection. 1990 Sep-Oct;18(5):294-8.
Bauernfeind A, Hohl P, Schneider I, Jungwirth R, Frei R. Escherichia coli producing
a cephamycinase (CMY-2) from a patient from the Libyan---Tunisian border
region. Clin Microbiol Infect. 1998 Mar;4(3):168-170.
Bauernfeind A, Stemplinger I, Jungwirth R, Mangold P, Amann S, Akalin E, Anğ O,
Bal C, Casellas JM. Characterization of beta-lactamase gene blaPER-2, which
encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents
Chemother.1996 Mar;40(3):616-20.
Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, Jaurin
B,Grundström T. The inhibition of class C beta-lactamases by boronic acids.
Biochem J. 1983 Jan 1;209(1):229-33.
Beier KH, Heegaard W, Rusnak RA. Acute neonatal scalp abscess and E coli
bacteremia in the ED. Am J Emerg Med. 1999 May;17(3):241-3
Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN. Prevalence and
significance of a negative extended-spectrum beta-lactamase (ESBL)
confirmation test result after a positive ESBL screening test result for isolates
of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY
Asia-Pacific Surveillance Program. J Clin Microbiol. 2007 May;45(5):1478-
82.
Bellais S, Poirel L, Fortineau N, Decousser JW, Nordmann P. Biochemical-genetic
characterization of the chromosomally encodedextended-spectrum class A
beta-lactamase from Rahnella aquatilis. Antimicrob Agents Chemother. 2001
Oct;45(10):2965-8.
140
Berardi A, Rossi C, Lugli L, Creti R, Bacchi Reggiani ML, Lanari M, Memo
L,Pedna MF, Venturelli C, Perrone E, Ciccia M, Tridapalli E, Piepoli M,
Contiero R,Ferrari F; GBS Prevention Working Group, Emilia-Romagna.
Group B streptococcus late-onset disease: 2003-2010. Pediatrics. 2013
Feb;131(2):e361-8. doi:10.1542/peds.2012-1231.
Bergström S, Normark S. Beta-lactam resistance in clinical isolates of Escherichia
coli caused by elevated production of the ampC-mediated chromosomal beta-
lactamase. Antimicrob Agents Chemother. 1979 Oct;16(4):427-33.
beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and
therapeutic challenge. J Perinatol. 2006 Aug;26(8):515-7.
beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and
therapeutic challenge. J Perinatol. 2006 Aug;26(8):515-7.
Bhattacharjee A, Sen MR, Prakash P, Gaur A, Anupurba S. Increased prevalence of
extended spectrum beta lactamase producers in neonatal septicaemic cases at a
tertiary referral hospital. Indian J Med Microbiol. 2008 Oct-Dec;26(4):356-60.
Bhutta ZA, Naqvi SH, Muzaffar T, Farooqui BJ. Neonatal sepsis in
Pakistan.Presentation and pathogens. Acta Paediatr Scand. 1991 Jun-Jul;80(6-
7):596-601.
Bhutta ZA, Zaidi AK, Thaver D, Humayun Q, Ali S, Darmstadt GL. Management of
newborn infections in primary care settings: a review of the evidence and
implications for policy? Pediatr Infect Dis J. 2009 Jan;28(1 Suppl):S22-30.
Bialkowska-Hobrzanska H, Jaskot D, Hammerberg O. Molecular characterization of
the coagulase-negative staphylococcal surface flora of premature neonates. J
Gen Microbiol. 1993 Dec;139(12):2939-44.
Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of
neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005 Sep;116(3):595-602.
Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-
mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal
AmpC beta-lactamases. J Clin Microbiol. 2005 ul;43(7):3110-3.
Black JA, Thomson KS, Buynak JD, Pitout JD. Evaluation of beta-lactamase
inhibitors in disk tests for detection of plasmid-mediated AmpC beta-
lactamases in well-characterized clinical strains of Klebsiella spp. J Clin
Microbiol. 2005 Aug;43(8):4168-71.
Black JA, Thomson KS, Pitout JD. Use of beta-lactamase inhibitors in disk tests to
detect plasmid-mediated AmpC beta-lactamases. J Clin Microbiol. 2004
May;42(5):2203-6.
141
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell
H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C; Child Health
Epidemiology Reference Group of WHO and UNICEF. Global, regional, and
national causes of child mortality in 2008: a systematic analysis. Lancet. 2010
Jun 5;375(9730):1969-87.
Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler
A,Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide
estimates of preterm birth rates in the year 2010 with time trends since 1990
for selected countries: a systematic analysis and implications. Lancet. 2012 Jun
9;379(9832):2162-72.
Bolat F, Uslu S, Bolat G, Comert S, Can E, Bulbul A, Nuhoglu A.Healthcare-
associated infections in a Neonatal Intensive Care Unit in Turkey.Indian
Pediatr. 2012 Dec;49(12):951-7.
Bonnet R, Sampaio JL, Chanal C, Sirot D, De Champs C, Viallard JL, Labia R,Sirot
J. A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia
marcescens isolated in Brazil. Antimicrob Agents Chemother. 2000
Nov;44(11):3061-8.
Boo NY, Ng SF, Lim VK. A case-control study of risk factors associated with rectal
colonization of extended-spectrum beta-lactamase producing Klebsiella sp. in
newborn infants. J Hosp Infect. 2005 Sep;61(1):68-74.
Bou Monterde R, Alfonso Diego J, Ferrando Monleón S, Sánchez-Villanueva
Bracho L, Aguilar Escriva A, Ramos Reig P. [Estimation of incidence and
analysis of sepsis in an area of Valencia (Spain)]. An Pediatr (Barc). 2007
Jun;66(6):573-7.
Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee.
Society for Healthcare Epidemiology of America. Association for
Professionals in Infection Control. Infectious Diseases Society of America.
Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care
Settings: recommendations of the Healthcare Infection Control Practices
Advisory Committee and theHICPAC/SHEA/APIC/IDSA Hand Hygiene Task
Force. Infect Control Hosp Epidemiol. 2002 Dec;23(12 Suppl):S3-40
Bradford PA. Extended-spectrum beta-lactamases in the 21st
century:characterization, epidemiology, and detection of this important
resistance threat. Clin Microbiol Rev. 2001 Oct;14(4):933-51.
Bradford PA. Extended-spectrum beta-lactamases in the 21st
century:characterization, epidemiology, and detection of this important
resistance threat. Clin Microbiol Rev. 2001 Oct;14(4):933-51.
Bratu S, Landman D, Martin DA, Georgescu C, Quale J. Correlation of antimicrobial
resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in
142
clinical isolates of Acinetobacter baumannii endemic to New York City.
Antimicrob Agents Chemother. 2008 Sep;52(9):2999-3005.
Brenwald NP, Jevons G, Andrews J, Ang L, Fraise AP. Disc methods for detecting
AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and
Klebsiella pneumoniae. J Antimicrob Chemother. 2005 Sep;56(3):600-1.
Brook I, Myhal LA, Dorsey CH. Encapsulation and pilus formation of Bacteroides
spp. in normal flora abscesses and blood. J Infect. 1992 Nov;25(3):251-7
Brook I. Infant botulism. J Perinatol. 2007 Mar;27(3):175-80.
Brown DF, Andrews J, King A, MacGowan AP. Detection of extended-spectrum
beta-lactamases with Etest and double-disc potentiation methods. J Antimicrob
Chemother. 2000 Aug;46(2):327-8.
Brown DG, Baublis J. Reservoirs of pseudomonas in an intensive care unit for
newborn infants: mechanisms of control. J Pediatr. 1977 Mar;90(3):453-7
Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval
J.Transferable enzymatic resistance to third-generation cephalosporins during
nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 1987
Aug 8;2(8554):302-6.
Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval
J.Transferable enzymatic resistance to third-generation cephalosporins during
nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 1987
Aug 8;2(8554):302-6
Brun-Buisson C. [Epidemiology of severe sepsis]. Presse Med. 2006 Mar;35(3 Pt
2):513-20.
Burman LG, Park JT, Lindström EB, Boman HG. Resistance of Escherichia coli to
penicillins: identification of the structural gene for the chromosomal
penicillinase. J Bacteriol. 1973 Oct;116(1):123-30.
Burman LG, Park JT, Lindström EB, Boman HG. Resistance of Escherichia coli to
penicillins: identification of the structural gene for the chromosomal
penicillinase. J Bacteriol. 1973 Oct;116(1):123-30.
Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-
lactamases and its correlation with molecular structure. Antimicrob Agents
Chemother. 1995 Jun;39(6):1211-33.
Bush K, Jacoby GA. Updated functional classification of beta-lactamases.
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76.
Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the
selection of antimicrobial therapy. Clin Infect Dis. 2001 Apr 1;32(7):1085-9
143
Calner PA, Salinas ML, Steck A, Schechter-Perkins E. Haemophilus influenza
Sepsis and Placental Abruption in an Unvaccinated Immigrant. West J Emerg
Med. 2012 Feb;13(1):133-5.
Cao VT, Arlet G, Ericsson BM, Tammelin A, Courvalin P, Lambert T. Emergence of
imipenem resistance in Klebsiella pneumoniae owing to combination of
plasmid-mediated CMY-4 and permeability alteration. J Antimicrob
Chemother. 2000 Dec;46(6):895-900
Carattoli A, Tosini F, Giles WP, Rupp ME, Hinrichs SH, Angulo FJ, Barrett TJ, Fey
PD. Characterization of plasmids carrying CMY-2 from expanded-spectrum
cephalosporin-resistant Salmonella strains isolated in the United States
between 1996 and 1998. Antimicrob Agents Chemother. 2002
May;46(5):1269-72.
Caroff N, Espaze E, Bérard I, Richet H, Reynaud A. Mutations in the ampC
promoter of Escherichia coli isolates resistant to oxyiminocephalosporins
without extended spectrum beta-lactamase production. FEMS Microbiol Lett.
1999 Apr 15;173(2):459-65.
Caroff N, Espaze E, Bérard I, Richet H, Reynaud A. Mutations in the ampC
promoter of Escherichia coli isolates resistant to oxyiminocephalosporins
without extended spectrum beta-lactamase production. FEMS Microbiol Lett.
1999 Apr 15;173(2):459-65.
Cavallo JD, Fabre R, Leblanc F, Nicolas-Chanoine MH, Thabaut A; Groupe d'Etude
de la Résistance de Pseudomonas aeruginosa aux Bêtalactamines. Antibiotic
susceptibility and mechanisms of beta-lactam resistance in 1310 strains of
pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob
Chemother. 2000 Jul;46(1):133-6
Chen Y, Minasov G, Roth TA, Prati F, Shoichet BK. The deacylation mechanism of
AmpC beta-lactamase at ultrahigh resolution. J Am Chem Soc. 2006 Mar
8;128(9):2970-6.
Chen YT, Lauderdale TL, Liao TL, Shiau YR, Shu HY, Wu KM, Yan JJ, Su IJ, Tsai
SF. Sequencing and comparative genomic analysis of pK29, a 269-kilobase
conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in
Klebsiella pneumoniae. Antimicrob Agents Chemother. 2007 Aug;51(8):3004-
7.
Chiabi A, Djoupomb M, Mah E, Nguefack S, Mbuagbaw L, Zafack J, Ghoyap M,
Nkoa T, Tchokoteu PF. The clinical and bacteriogical spectrum of neonatal
sepsis in a tertiary hospital in yaounde, cameroon. Iran J Pediatr. 2011
Dec;21(4):441-8.
Chiu S, Huang YC, Lien RI, Chou YH, Lin TY. Clinical features of nosocomial
infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae
in neonatal intensive care units. Acta Paediatr. 2005 Nov;94(11):1644-9.
144
Choi SH, Lee JE, Park SJ, Choi SH, Lee SO, Jeong JY, Kim MN, Woo JH, Kim YS.
Emergence of antibiotic resistance during therapy for infections caused by
Enterobacteriaceae producing AmpC beta-lactamase: implications for
antibiotic use. Antimicrob Agents Chemother. 2008 Mar;52(3):995-1000.
Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal
R,Wagener MM, Miyashiro DK, Yu VL. Enterobacter bacteremia: clinical
features and emergence of antibiotic resistance during therapy. Ann Intern
Med. 1991 Oct 15;115(8):585-90.
Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and
cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for
sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006
Jan;117(1):67-74.
Clinical and Laboratory Standard Institute, 2006. Performance standards for
antimicrobial susceptibility testing: sixteenth informational supplement. CLSI
document M100-S16. CLSI, Wayne, Pa.
Clinical and Laboratory Standards Institute. Performance Standards for
Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement
M100-S19. Wayne, PA, USA: CLSI; 2009.
Clinical and Laboratory Standards Institute. Performance Standards for
Antimicrobial Susceptibility Testing: Twentieth Informational Supplement
M100-S20.Wayne, PA, USA: CLSI; 2010.
Clinical and Laboratory Standards Institute. Performance Standards for
Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement
M 100-S21. Wayne, PA, USA: CLSI; 2011.
Cohen-Wolkowiez M, Benjamin DK Jr, Capparelli E. Immunotherapy in neonatal
sepsis: advances in treatment and prophylaxis. Curr Opin Pediatr. 2009
Apr;21(2):177-81.
Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum beta-
lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin
Microbiol. 1996 Aug;34(8):1880-4.
Corvec S, Prodhomme A, Giraudeau C, Dauvergne S, Reynaud A, Caroff N. Most
Escherichia coli strains overproducing chromosomal AmpC beta-lactamase
belong to phylogenetic group A. J Antimicrob Chemother. 2007
Oct;60(4):872-6.
Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, Ambalavanan
N, Benjamin DK Jr; NICHD Neonatal Research Network. Prolonged duration
of initial empirical antibiotic treatment is associated with increased rates of
necrotizing enterocolitis and death for extremely low birth weight infants.
Pediatrics. 2009 Jan;123(1):58-66.
145
Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-
lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus
mirabilis isolates at a veterans medical center. J Clin Microbiol. 2000
May;38(5):1791-6.
Crivaro V, Di Popolo A, Caprio A, Lambiase A, Di Resta M, Borriello T,Scarcella
A, Triassi M, Zarrilli R. Pseudomonas aeruginosa in a neonatal intensive care
unit: molecular epidemiology and infection control measures. BMC Infect Dis.
2009 May 22;9:70.
Darmstadt GL, Zaidi AKM, Stoll BJ. Infectious Diseases of the Fetus and Newborn
Infant, 7th
ed. Philadelphia, Elsevier: 2011.
Das PK, Basu K, Chakraborty P, Bhowmik PK. Clinical and bacteriological profile
of neonatal infections in metropolitan city based medical college nursery. J
Indian Med Assoc. 1999 Jan;97(1):3-5.
Datta N, Kontomichalou P. Penicillinase synthesis controlled by infectious R factors
in Enterobacteriaceae. Nature. 1965 Oct 16;208(5007):239-41.
Dear P. Infection in the newborn. Textbook of Neonatology. 4th
ed. Philadelphia:
Elsevier: 2005.
Decré D, Burghoffer B, Gautier V, Petit JC, Arlet G. Outbreak of multi-resistant
Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases
and strains with extended-spectrum activity of the chromosomal beta-
lactamase. J Antimicrob Chemother. 2004 Nov;54(5):881-8.
Ding H, Yang Y, Lu Q, Wang Y, Chen Y, Deng L, Wang A, Deng Q, Zhang H,
Wang C,Liu L, Xu X, Wang L, Shen X. The prevalence of plasmid-mediated
AmpC beta-lactamases among clinical isolates of Escherichia coli and
Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin
Microbiol Infect Dis. 2008 Oct;27(10):915-21.
Doi Y, Paterson DL. Detection of plasmid-mediated class C beta-lactamases. Int J
Infect Dis. 2007 May;11(3):191-7.
Dong F, Xu XW, Song WQ. [Prevalence of plasmid-mediated AmpC beta-
lactamases in Escherichia coli and Klebsiella spp. isolated in children].
Zhonghua Yi Xue Za Zhi. 2010 Oct 19;90(38):2723-5.
Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol
Rev. 2010 Jan;23(1):160-201.
Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-
spectrum beta-lactamase production in Enterobacteriaceae: review and bench
guide. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:90-103.
146
Du W, Warrier I, Tutag Lehr V, Salari V, Ostrea E, Aranda JV. Changing patterns of
drug utilization in a neonatal intensive care population. Am J Perinatol. 2006
Jul;23(5):279-85.
Dubus A, Ledent P, Lamotte-Brasseur J, Frère JM. The roles of residues Tyr150,
Glu272, and His314 in class C beta-lactamases. Proteins. 1996 Aug;25(4):473-
85.
Elhag KM, Mustafa AK, Sethi SK. Septicaemia in a teaching hospital in Kuwait--I:
Incidence and aetiology. J Infect. 1985 Jan;10(1):17-24
Ensor VM, Shahid M, Evans JT, Hawkey PM. Occurrence, prevalence and genetic
environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian
hospitals. J Antimicrob Chemother. 2006 Dec;58(6):1260-3.
Eriksson-Grennberg KG, Boman HG, Jansson JA, Thorén S. Resistance of
Escherichia coli to Penicillins I. Genetic Study of Some Ampicillin-Resistant
Mutants. J Bacteriol. 1965 Jul;90(1):54-62.
Eriksson-Grennberg KG. Resistance of Escherichia coli to penicillins. II. An
improved mapping of the ampA gene. Genet Res. 1968 Oct;12(2):147-56.
Erratum in: Antimicrob Agents Chemother 1992 Nov;36(11):2575. PubMed PMID:
1416878 Evaluation of methods for AmpC beta-lactamase in gram negative
clinical isolates from tertiary care hospitals. Indian J Med Microbiol. 2005
Apr;23(2):120-4.
European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for
interpretation of MICs and zone diameters. EUCAST; 2010. Version 1.1 http
European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for
interpretation of MICs and zone diameters. EUCAST; 2011. Version 1.3
European Committee on Antimicrobial Susceptibility Testing. Expert Rules in
antimicrobial susceptibility testing. EUCAST; 2008.
Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates
from tertiary care hospitals. Indian J Med Microbiol. 2005 Apr;23(2):120-4.
Fakioglu E, Queenan AM, Bush K, Jenkins SG, Herold BC. Amp C
false-positive results obtained with the Hodge and Masuda assays for detection of
class a carbapenemase in species of enterobacteriaceae by incorporating
boronic Acid. J Clin Microbiol. 2010 Apr;48(4):1323-32.
Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, Tyson JE,
Philips JB 3rd, Edwards W, Lucey JF, Catz CS, Shankaran S, Oh W.
Incidence, presenting features, risk factors and significance of late onset
septicemia in very low birth weight infants. The National Institute of Child
147
Health and Human Development Neonatal Research Network. Pediatr Infect
Dis J. 1998 Jul;17(7):593-8.
Fierer J, Taylor PM, Gezon HM. Pseudomonas aeruginosa epidemic traced to
delivery-room resuscitators. N Engl J Med. 1967 May 4;276(18):991-6
Flaatten H. Epidemiology of sepsis in Norway in 1999. Crit Care. 2004
Aug;8(4):R180-4.
Fleming A: On the antibacterial action of cultures of a penicillium, with special
reference to their use in the isolation of B. influenza[ Br J Exp Pathol
1929,10(31):226-236.
Franceschini N, Galleni M, Frère JM, Oratore A, Amicosante G. A class-A beta-
lactamase from Pseudomonas stutzeri that is highly active against
monobactams and cefotaxime. Biochem J. 1993 Jun 15;292 ( Pt 3):697-700.
Franz AR, Bauer K, Schalk A, Garland SM, Bowman ED, Rex K, Nyholm C,
Norman M,Bougatef A, Kron M, Mihatsch WA, Pohlandt F; International IL-8
Study Group.Measurement of interleukin 8 in combination with C-reactive
protein reduced unnecessary antibiotic therapy in newborn infants: a
multicenter, randomized,controlled trial. Pediatrics. 2004 Jul;114(1):1-8.
Freedman RM, Ingram DL, Gross I, Ehrenkranz RA, Warshaw JB, Baltimore RS. A
half century of neonatal sepsis at Yale: 1928 to 1978. Am J Dis Child. 1981
Feb;135(2):140-4.
Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of
Candida bloodstream infections among NICU patients in the United States:
1995-2004. Pediatrics. 2006 May;117(5):1680-7
Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of
understaffing in central venous catheter-associated bloodstream infections.
Infect Control Hosp Epidemiol. 1996 Mar;17(3):150-8.
Friesen CA, Cho CT. Characteristic features of neonatal sepsis due to Haemophilus
influenzae. Rev Infect Dis. 1986 Sep-Oct;8(5):777-80.
Gardner SL. Sepsis in the neonate. Crit Care Nurs Clin North Am. 2009
Mar;21(1):121-41, vii. doi: 10.1016/j.ccell.2008.11.002.
Gastmeier P, Groneberg K, Weist K, Rüden H. A cluster of nosocomial Klebsiella
pneumoniae bloodstream infections in a neonatal intensive care department:
Identification of transmission and intervention. Am J Infect Control. 2003
Nov;31(7):424-30.
Gazouli M, Tzouvelekis LS, Prinarakis E, Miriagou V, Tzelepi E. Transferable
cefoxitin resistance in enterobacteria from Greek hospitals and characterization
148
of a plasmid-mediated group 1 beta-lactamase (LAT-2). Antimicrob Agents
Chemother. 1996 Jul;40(7):1736-40.
Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr
Clin North Am. 2004 Aug;51(4):939-59.
Giakkoupi P, Tzouvelekis LS, Tsakris A, Loukova V, Sofianou D, Tzelepi E IBC-1,
a novel integron-associated class A beta-lactamase with extended-spectrum
properties produced by an Enterobacter cloacae clinical strain. Antimicrob
Agents Chemother. 2000 Sep;44(9):2247-53.
Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature
birth and subclinical infection. Am J Obstet Gynecol. 1992 May;166(5):1515-
28.Review.
Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P. Heterogeneity of
AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible
or constitutive ceftazidime resistance phenotypes. Antimicrob Agents
Chemother. 2000 Nov;44(11):3220-3
Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm
delivery. N Engl J Med. 2000 May 18;342(20):1500-7.
Gonzalez Leiza M, Perez-Diaz JC, Ayala J, Casellas JM, Martinez-Beltran J, Bush
K, Baquero F. Gene sequence and biochemical characterization of FOX-1 from
Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase
with two molecular variants. Antimicrob Agents Chemother. 1994
Sep;38(9):2150-7
Gordon A, Isaacs D. Late-onset infection and the role of antibiotic prescribing
policies. Curr Opin Infect Dis. 2004 Jun;17(3):231-6.
Gray JW. Surveillance of infection in neonatal intensive care units. Early Hum Dev.
2007 Mar;83(3):157-63. Epub 2007 Feb 7.
Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, Levine GL, Goldmann DA,
Jarvis WR; Pediatric Prevention Network. Use of antimicrobial agents in
United States neonatal and pediatric intensive care patients. Pediatr Infect Dis
J. 2005 Sep;24(9):766-73
Grundmann H, Kropec A, Hartung D, Berner R, Daschner F. Pseudomonas
aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the
nosocomial pathogen. J Infect Dis. 1993 Oct;168(4):943-7
Guha DK, Jaspal D, Das K, Guha AR, Khatri RL, Kumar RS. Outcome of neonatal
septicemia: a clinical and bacteriological profile. Indian Pediatr. 1978
May;15(5):423-7.
149
Gupta AK, Shashi S, Mohan M, Lamba IM, Gupta R. Epidemiology of Pseudomonas
aeruginosa infections in a neonatal intensive care unit. J Trop Pediatr. 1993
Feb;39(1):32-6.
Gur D, Hascelik G, Aydin N, Telli M, Gültekin M, Ogülnç D, Arikan OA, Uysal S,
Yaman A, Kibar F, Gülay Z, Sumerkan B, Esel D, Kayacan CB, Aktas Z,
Soyletir G,Altinkanat G, Durupinar B, Darka O, Akgün Y, Yayla B, Gedikoglu
S, Sinirtas M,Berktas M, Yaman G. Antimicrobial resistance in gram-negative
hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. J
Chemother. 2009 Aug;21(4):383-9.
Gurbuz A, Karateke A, Yilmaz U, Kabaca C. The role of perinatal and intrapartum
risk factors in the etiology of cerebral palsy in term deliveries in a Turkish
population. J Matern Fetal Neonatal Med. 2006 Mar;19(3):147-55.
Hageman JC, Fridkin SK, Mohammed JM, Steward CD, Gaynes RP, Tenover
FC;National Nosocomial Infections Surveillance System Hospitals.
Antimicrobial proficiency testing of National Nosocomial Infections
Surveillance System hospital laboratories. Infect Control Hosp Epidemiol.
2003 May;24(5):356-61
Haines A, Cassels A. Can the millennium development goals be attained? BMJ.2004
Aug 14;329(7462):394-7.
Hall BG, Barlow M. Evolution of the serine beta-lactamases: past, present and
future. Drug Resist Updat. 2004 Apr;7(2):111-23.
Hanson ND, Sanders CC. Regulation of inducible AmpC beta-lactamase expression
among Enterobacteriaceae. Curr Pharm Des. 1999 Nov;5(11):881-94.
Hanson ND, Thomson KS, Moland ES, Sanders CC, Berthold G, Penn RG.
Molecular characterization of a multiply resistant Klebsiella pneumoniae
encoding ESBLs and a plasmid-mediated AmpC. J Antimicrob Chemother.
1999 Sep;44(3):377-80.
Hanson ND. AmpC beta-lactamases: what do we need to know for the future? J
Antimicrob Chemother. 2003 Jul;52(1):2-4. Epub 2003 May 29.
Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in
Asia. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:159-65. Review. Erratum in:
Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4.
Healy CM, Baker CJ, Palazzi DL, Campbell JR, Edwards MS. Distinguishing true
coagulase-negative Staphylococcus infections from contaminants in the
neonatal intensive care unit. J Perinatol. 2013 Jan;33(1):52-8.
Hei MY, Zhang XC, Gao XY, Zhao LL, Wu ZX, Tian L, Tan YJ. Catheter-related
infection and pathogens of umbilical venous catheterization in a neonatal
intensive care unit in China. Am J Perinatol. 2012 Feb;29(2):107-14.
150
Hemalatha V, Padma M, Sekar U, Vinodh TM, Arunkumar AS. Detection of Amp C
beta lactamases production in Escherichia coli & Klebsiella by an inhibitor
based method. Indian J Med Res. 2007 Sep;126(3):220-3.
Héritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from
insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect. 2006
Feb;12(2):123-30
Hernández-Allés S, Conejo Md, Pascual A, Tomás JM, Benedí VJ, Martínez-
Martínez L. Relationship between outer membrane alterations and
susceptibility to antimicrobial agents in isogenic strains of Klebsiella
pneumoniae. J Antimicrob Chemother. 2000 Aug;46(2):273-7.
Himmelmann K, Hagberg G, Wiklund LM, Eek MN, Uvebrant P. Dyskinetic
cerebral palsy: a population-based study of children born between 1991 and
1998. Dev Med Child Neurol. 2007 Apr;49(4):246-51.
Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y,
Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN, Kohno S;
SENTRY Asia-Pacific Participants. Regional variation in the prevalence of
extended-spectrum beta-lactamase-producing clinical isolates in the Asia-
Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis. 2005
Aug;52(4):323-9.
Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of a novel, inhibitor-
potentiated disc-diffusion test with other methods for the detection of
extended-spectrum beta-lactamases in Escherichia coli and Klebsiella
pneumoniae. J Antimicrob Chemother. 1998 Jul;42(1):49-54.
Holten KB, Onusko EM. Appropriate prescribing of oral beta-lactam antibiotics. Am
Fam Physician. 2000 Aug 1;62(3):611-20.
Honoré N, Nicolas MH, Cole ST. Inducible cephalosporinase production in clinical
isolates of Enterobacter cloacae is controlled by a regulatory gene that has
been deleted from Escherichia coli. EMBO J. 1986 Dec 20;5(13):3709-14.
Hood M, Janney A, Dameron G. Beta hemolytic streptococcus group B associated
with problems of the perinatal period. Am J Obstet Gynecol. 1961 Oct;82:809-
18.
Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr
KA, Pfaller MA, Chang CH, Webster KM. Epidemiology and outcomes of
candidemia in 2019 patients: data from the prospective antifungal therapy
alliance registry. Clin Infect Dis. 2009 Jun 15;48(12):1695-703.
Hoşbul T, Ozyurt M, Karademir F, Süleymanoğlu S, Haznedaroğlu T.[Investigation
of a nosocomial outbreak caused by ESBL positive Klebsiella pneumoniae in
neonatal intensive care unit by AP-PCR]. Mikrobiyol Bul. 2012 Jan;46(1):101-
5.
151
Hospital Infection Control Practices Advisory Committee (HICPAC).
Recommendations for preventing the spread of vancomycin resistance. Infect
Control Hosp Epidemiol. 1995 Feb;16(2):105-13. Review. Erratum in: Infect
Control Hosp Epidemiol 1995 Sep;16(9):498.
Huang YC, Li CC, Lin TY, Lien RI, Chou YH, Wu JL, Hsueh C. Association of
fungal colonization and invasive disease in very low birth weight infants.
Pediatr Infect Dis J. 1998 Sep;17(9):819-22.
Huovinen P, Huovinen S, Jacoby GA. Sequence of PSE-2 betalactamase. Antimicrob
Agents Chemother 1988; 32: 134–6.
Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, Cha SB, Yoo
HS.Prevalence of class A and AmpC β-lactamases in clinical Escherichia coli
isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J
Infect Dis. 2011;64(3):249-52.
Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob
Agents Chemother. 1991 Sep;35(9):1697-704.
Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and
carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella
pneumoniae by disk tests. J Clin Microbiol. 2006 Jun;44(6):1971-6.
Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009 Jan;22(1):161-82,
Table of Contents. doi: 10.1128/CMR.00036-08.
Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing
resistance to oxyimino-beta-lactams. Infect Dis Clin North Am. 1997
Dec;11(4):875-87.
Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum
beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a
tertiary care hospital. J Med Microbiol. 2003 May;52(Pt 5):421-5
Jain NK, Jain VM, Maheshwari S. Clinical profile of neonatal sepsis. Kathmandu
Univ Med J (KUMJ). 2003 Apr-Jun;1(2):117-20.
Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-
lactamases conferring transferable resistance to newer beta-lactam agents in
Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect
Dis. 1988 Jul-Aug;10(4):867-78.
Jaurin B, Grundström T, Normark S. Sequence elements determining ampC
promoter strength in E. coli. EMBO J. 1982;1(7):875-81.
Jaurin B, Grundström T. ampC cephalosporinase of Escherichia coli K-12 has a
different evolutionary origin from that of beta-lactamases of the Penicillinase
type. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4897-901.
152
Jaurin B, Grundström T. ampC cephalosporinase of Escherichia coli K-12 has a
different evolutionary origin from that of beta-lactamases of the penicillinase
type. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4897-901.
Jaurin B, Normark S. Insertion of IS2 creates a novel ampC promoter in Escherichia
coli. Cell. 1983 Mar;32(3):809-16.
Jehan I, Harris H, Salat S, Zeb A, Mobeen N, Pasha O, McClure EM, Moore
J,Wright LL, Goldenberg RL. Neonatal mortality, risk factors and causes: a
prospective population-based cohort study in urban Pakistan. Bull World
Health Organ. 2009 Feb;87(2):130-8.
Jeong SH, Kim WM, Chang CL, Kim JM, Lee K, Chong Y, Hwang HY, Baek YW,
Chung HK, Woo IG, Ku JY. Neonatal intensive care unit outbreak caused by a
strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of
chromosomal beta-lactamase. J Hosp Infect. 2001 Aug;48(4):281-8.
Joris B, Ledent P, Dideberg O, Fonzé E, Lamotte-Brasseur J, Kelly JA, Ghuysen JM,
Frère JM. Comparison of the sequences of class A beta-lactamases and of the
secondary structure elements of penicillin-recognizing proteins. Antimicrob
Agents Chemother. 1991 Nov;35(11):2294-301.
Juan C, Moyá B, Pérez JL, Oliver A. Stepwise upregulation of the Pseudomonas
aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam
resistance involves three AmpD homologues. Antimicrob Agents Chemother.
2006 May;50(5):1780-7.
Kaftan H, Kinney JS. Early onset neonatal bacterial infections. Semin Perinatol.
1998 Feb;22(1):15-24.
Kaistha N, Mehta M, Singla N, Garg R, Chander J. Neonatal septicemia isolates and
resistance patterns in a tertiary care hospital of North India. J Infect Dev
Ctries. 2009 Nov 13;4(1):55-7
Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid-mediated extended-spectrum
beta-lactamase (CTX-M-3 like) from India and gene association with insertion
sequence ISEcp1. FEMS Microbiol Lett. 2001 Jul 24;201(2):237-41
Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal
intensive care unit, 1988-1997, and the impact of avoiding empiric
vancomycin therapy. Pediatrics. 2000 Dec;106(6):1387-90.
Karlsson S, Varpula M, Ruokonen E, Pettilä V, Parviainen I, Ala-Kokko TI,Kolho E,
Rintala EM. Incidence, treatment, and outcome of severe sepsis in ICU-treated
adults in Finland: the Finnsepsis study. Intensive Care Med. 2007
Mar;33(3):435-43.
153
Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella
pneumoniae and Escherichia coli strains producing extended-spectrum beta-
lactamases. J Clin Microbiol. 1994 Mar;32(3):691-6.
Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole
prophylaxis against fungal colonization and infection in preterm infants. N
Engl J Med. 2001 Dec 6;345(23):1660-6.
Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in
very-low-birth-weight infants. Clin Microbiol Rev. 2004 Jul;17(3):638-80,
table of contents.
Kaye KS, Cosgrove S, Harris A, Eliopoulos GM, Carmeli Y. Risk factors for
emergence of resistance to broad-spectrum cephalosporins among Enterobacter
spp. Antimicrob Agents Chemother. 2001 Sep;45(9):2628-30.
Ketevan Nemsadze. Neonatal Bacterial Infection. Bernhard Resch :2010.
Khan MK, Thukral SS, Gaind R. Evaluation of a modified double-disc synergy test
for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-
producing proteus mirabilis. Indian J Med Microbiol. 2008 Jan-Mar;26(1):58-
61.
Kilbride HW, Powers R, Wirtschafter DD, Sheehan MB, Charsha DS, LaCorte M,
Finer N, Goldmann DA. Evaluation and development of potentially better
practices to prevent neonatal nosocomial bacteremia. Pediatrics. 2003
Apr;111(4 Pt 2):e504-18.
Kirby Wm. Extraction Of A Highly Potent Penicillin Inactivator From Penicillin
Resistant Staphylococci. Science. 1944 Jun 2;99(2579):452-3.
Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by
methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg
Infect Dis. 2007 Dec;13(12):1840-6.
Klein JO. Infectious Diseases of the Fetus and Newborn, 5th
Edition Edited by Jack
S. Remington and Jerome O. Klein Philadelphia: WB Saunders: 2001.
Knights HT, France DR, Harding S. Psuedomonas aeruginosa cross infection in a
neonatal unit. N Z Med J. 1968 Jun;67(433):617-20
Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to
cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates
ofKlebsiella pneumoniae and Serratia marcescens. Infection. 1983. Nov-
Dec;11(6):315-7.
Knott-Hunziker V, Petursson S, Jayatilake GS, Waley SG, Jaurin B, Grundström T.
Active sites of beta-lactamases. The chromosomal beta-lactamases of
154
Pseudomonas aeruginosa and Escherichia coli. Biochem J. 1982 Mar
1;201(3):621-7.
Knox JR, Moews PC, Frere JM. Molecular evolution of bacterial beta-lactam
resistance. Chem Biol. 1996 Nov;3(11):937-47.
Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra
S,Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP,
McCormack JG, Yu VL. Community-acquired Klebsiella pneumoniae
bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002
Feb;8(2):160-6.
Kohner PC, Robberts FJ, Cockerill FR 3rd, Patel R. Cephalosporin MIC distribution
of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia
coli and Klebsiella species. J Clin Microbiol. 2009 Aug;47(8):2419-25.
Kothari C, Gaind R, Singh LC, Sinha A, Kumari V, Arya S, Chellani H, Saxena
S,Deb M. Community acquisition of β-lactamase producing
Enterobacteriaceae in neonatal gut. BMC Microbiol. 2013 Jun 17;13:136. doi:
10.1186/1471-2180-13-136.
Krediet T, Gerards L, Fleer A, van Stekelenburg G. The predictive value of CRP and
I/T-ratio in neonatal infection. J Perinat Med. 1992;20(6):479-85.
Krediet TG, Jones ME, Gerards LJ, Fleer A. Clinical outcome of cephalothin versus
vancomycin therapy in the treatment of coagulase-negative staphylococcal
septicemia in neonates: relation to methicillin resistance and mec A gene
carriage of blood isolates. Pediatrics. 1999 Mar;103(3):E29.
Ku NS (Naehi), Kim YC, Kim MH, Song JE, Oh DH, Ahn JY, Kim SB, Kim HW,
Jeong SJ, Han SH, Kim CO, Song YG, Kim JM, Choi JY. Risk factors for 28-
day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-
producing Escherichia coli and Klebsiella pneumoniae bacteremia. Arch
Gerontol Geriatr. 2013 Aug 8.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan
R,Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV,
Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R,
Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J,
Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. Emergence
of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a
molecular, biological, and epidemiological study. Lancet Infect Dis. 2010
Sep;10(9):597-602. doi: 10.1016/S1473-3099(10)70143-2.
Kuruvilla KA, Pillai S, Jesudason M, Jana AK. Bacterial profile of sepsis in a
neonatal unit in south India. Indian Pediatr. 1998 Sep;35(9):851-8.
Labia R. Analysis of the bla(toho) gene coding for Toho-2-beta-lactamase.
Antimicrob Agents Chemother. 1999 Oct;43(10):2576-7.
155
Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME;
European Union Invasive Bacterial Infection Surveillance participants.
Invasive Haemophilus influenzae Disease, Europe, 1996-2006. Emerg Infect
Dis. 2010 Mar;16(3):455-63.
Lahariya C. State of the World's Children 2008. Indian Pediatr. 2008 Mar;45(3):222-
3
Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM & SHV gene in extended
spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a
tertiary care hospital. Indian J Med Res. 2007 Feb;125(2):173-8.
Lam BC, Lee J, Lau YL. Hand hygiene practices in a neonatal intensive care unit: a
multimodal intervention and impact on nosocomial infection. Pediatrics. 2004
Nov;114(5):e565-71.
Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C,
Brooks S. Citywide clonal outbreak of multiresistant Acinetobacter baumannii
and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has
returned. Arch Intern Med. 2002 Jul 8;162(13):1515-20
Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract.
Clin Infect Dis. 2001 Feb 15;32(4):e69-77.
Larson E, Kretzer EK. Compliance with handwashing and barrier precautions. J
Hosp Infect. 1995 Jun;30 Suppl:88-106.
Larson EL, Albrecht S, O'Keefe M. Hand hygiene behavior in a pediatric emergency
department and a pediatric intensive care unit: comparison of use of 2
dispenser systems. Am J Crit Care. 2005 Jul;14(4):304-11.
Lawn JE, Lee AC, Kinney M, Sibley L, Carlo WA, Paul VK, Pattinson R, Darmstadt
GL. Two million intrapartum-related stillbirths and neonatal deaths: where,
why, and what can be done? Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S5-
18, S19. doi: 10.1016/j.ijgo.2009.07.016.
Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. First report of Klebsiella oxytoca
strain coproducing KPC-2 and IMP-8 carbapenemases. Antimicrob Agents
Chemother. 2011 Jun;55(6):2937-41. doi: 10.1128/AAC.01670-10.
Lin JW, Weng SF, Chao YF, Chung YT. Characteristic analysis of the ampC gene
encoding beta-lactamase from Photobacterium phosphoreum. Biochem
Biophys Res Commun. 2005 Jan 21;326(3):539-47.
Lin SY, Ho MW, Yang YF, Liu JH, Wang IK, Lin SH, Huang CC. Abscess caused
by Citrobacter koseri infection: three case reports and a literature review.
Intern Med. 2011;50(12):1333-7. Epub 2011 Jun 15.
156
Linkin DR, Fishman NO, Patel JB, Merrill JD, Lautenbach E. Risk factors for
extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal
intensive care unit. Infect Control Hosp Epidemiol. 2004 Sep;25(9):781-3
Linström EB, Boman HG, Steele BB. Resistance of Escherichia coli to penicillins.
VI. Purification and characterization of the chromosomally mediated
penicillinase present in ampA-containing strains. J Bacteriol. 1970
an;101(1):218-31.
Lister PD, Gardner VM, Sanders CC. Clavulanate induces expression of the
Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant
concentrations and antagonizes the antibacterial activity of ticarcillin.
Antimicrob Agents Chemother. 1999 Apr;43(4):882-9
Litzow JM, Gill CJ, Mantaring JB, Fox MP, MacLeod WB, Mendoza M, Mendoza
S,Scobie R, Huskins CW, Goldman DA, Hamer DH. High frequency of
multidrug-resistant gram-negative rods in 2 neonatal intensive care units in the
Philippines. Infect Control Hosp Epidemiol. 2009 Jun;30(6):543-9.
Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H,
Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology
Reference Group of WHO and UNICEF. Global, regional, and national causes
of child mortality: an updated systematic analysis for 2010 with time trends
since 2000. Lancet. 2012 un 9;379(9832):2151-61.
Livermore DM, Warner M, Mushtaq S. Evaluation of the chromogenic Cica-beta-
Test for detecting extended-spectrum, AmpC and metallo-beta- lactamases.J
Antimicrob Chemother. 2007 Dec;60(6):1375-9.
Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect
Dis. 2003 Jan 15;36(Suppl 1):S11-23.
Livermore DM. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol
Rev. 1995 Oct;8(4):557-84.
Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas
aeruginosa: our worst nightmare? Clin Infect Dis. 2002 Mar 1;34(5):634-40.
Lobkovsky E, Moews PC, Liu H, Zhao H, Frere JM, Knox JR. Evolution of an
enzyme activity: crystallographic structure at 2-A resolution of
cephalosporinases from the ampC gene of Enterobacter cloacae P99 and
comparison with a class A penicillinase. Proc Natl Acad Sci U S A. 1993 Dec
1;90(23):11257-61.
López Sastre JB, Coto Cotallo GD, Fernández Colomer B; Grupo de Hospitales
Castrillo. Neonatal sepsis of vertical transmission: an epidemiological study
from the "Grupo de Hospitales Castrillo". J Perinat Med. 2000;28(4):309-15
157
Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin
Invest. 2003 May;111(9):1265-73.
Lund AM, Christensen E, Skovby F. [Diagnosis and acute treatment of inborn
metabolic diseases in infants]. Ugeskr Laeger. 2002 Nov 25;164(48):5613-9.
Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, Niki M, Komalamisra
C, Kusolsuk T, Yamamoto Y. Prevalence of and risk factors associated with
faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural
Thai communities. J Antimicrob Chemother. 2012 Jul;67(7):1769-74.
Ma L, Ishii Y, Ishiguro M, Matsuzawa H, Yamaguchi K. Cloning and sequencing of
the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by
tazobactam. Antimicrob Agents Chemother. 1998 May;42(5):1181-6.
Mahmood A, Karamat KA, Butt T. Neonatal sepsis: high antibiotic resistance of the
bacterial pathogens in a neonatal intensive care unit in Karachi. J Pak Med
Assoc. 2002 Aug;52(8):348-50.
Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with
acquired fungal sepsis: further characterization. Pediatrics. 2001
Jan;107(1):61-6.
Mammeri H, Eb F, Berkani A, Nordmann P. Molecular characterization of AmpC-
producing Escherichia coli clinical isolates recovered in a French hospital.J
Antimicrob Chemother. 2008 Mar;61(3):498-503.
Mammeri H, Nordmann P, Berkani A, Eb F. Contribution of extended-spectrum
AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
FEMS Microbiol Lett. 2008 May;282(2):238-40.
Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases
among Gram-negative clinical isolates using a modified three-dimensional test
at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother. 2003
Feb;51(2):415-8.
Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic
carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide
prevalence, interinstitutional spread, and relation to antibiotic usage. Clin
Infect Dis. 2000 Jul;31(1):101-6.
Mannik M, Baringer Jr, Stokes J 3rd. Infections due to group B beta-hemolytic
streptococci. Report of three cases and review of the literature. N Engl J
Med.1962 May 3;266:910-3
Manoharan A, Sugumar M, Kumar A, Jose H, Mathai D, Khilnani GC, Kapil
A,Francis G, Radhakrishnan K, Dutta TK, Parija SC, Narang R, Mendiratta
DK, Deotale V, Baronia AK, Prasad KN. Phenotypic & molecular
characterization of AmpC β-lactamases among Escherichia coli, Klebsiella
158
spp. & Enterobacter spp. From five Indian Medical Centers. Indian J Med Res.
2012 Mar;135:359-64.
Manzoni P, Farina D, Leonessa M, d'Oulx EA, Galletto P, Mostert M, Miniero R,
Gomirato G. Risk factors for progression to invasive fungal infection in
preterm neonates with fungal colonization. Pediatrics. 2006 Dec;118(6):2359-
64.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the
United States from 1979 through 2000. N Engl J Med. 2003 Apr
17;348(16):1546-54.
Martínez-Martínez L, Conejo MC, Pascual A, Hernández-Allés S, Ballesta S,
Ramírez De Arellano-Ramos E, Benedí VJ, Perea EJ. Activities of imipenem
and cephalosporins against clonally related strains of Escherichia coli
hyperproducing chromosomal beta-lactamase and showing altered porin
profiles. Antimicrob Agents Chemother. 2000 Sep;44(9):2534-6
Martínez-Martínez L, Hernández-Allés S, Albertí S, Tomás JM, Benedi VJ, Jacoby
GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae
with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.
Antimicrob Agents Chemother. 1996 Feb;40(2):342-8.
Martínez-Martínez L, Pascual A, Hernández-Allés S, Alvarez-Díaz D, Suárez
AI,Tran J, Benedí VJ, Jacoby GA. Roles of beta-lactamases and porins in
activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
Antimicrob Agents Chemother. 1999 Jul;43(7):1669-73
Martínez-Martínez L. Relationship between outer membrane alterations and
susceptibility to antimicrobial agents in isogenic strains of Klebsiella
pneumoniae. J Antimicrob Chemother. 2000 Aug;46(2):273-7.
Marzban A, Samaee H, Mosavinasab N. Changing trend of empirical antibiotic
regimen: experience of two studies at different periods in a neonatal intensive
care unit in Tehran, Iran. Acta Med Iran. 2010 Sep-Oct;48(5):312-5
Mathai D, Rhomberg PR, Biedenbach DJ, Jones RN; India Antimicrobial Resistance
Study Group. Evaluation of the in vitro activity of six broad-spectrum beta-
lactam antimicrobial agents tested against recent clinical isolates from India: a
survey of ten medical center laboratories. Diagn Microbiol Infect Dis. 2002
Dec;44(4):367-77
Matsubara N, Yotsuji A, Kumano K, Inoue M, Mitsuhashi S. Purification and some
properties of a cephalosporinase from Proteus vulgaris. Antimicrob Agents
Chemother. 1981 Jan;19(1):185-7.
Matsumoto Y, Inoue M. Characterization of SFO-1, a plasmid-mediated inducible
class A beta-lactamase from Enterobacter cloacae. Antimicrob Agents
Chemother. 1999 Feb;43(2):307-13.
159
Mavroidi A, Tzelepi E, Tsakris A, Miriagou V, Sofianou D, Tzouvelekis LS. An
integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a
variant of the extended-spectrum beta-lactamase IBC-1. J Antimicrob
Chemother. 2001 Nov;48(5):627-30.
McDonald LC, Walker M, Carson L, Arduino M, Aguero SM, Gomez P, McNeil
P,Jarvis WR. Outbreak of Acinetobacter spp. bloodstream infections in a
nursery associated with contaminated aerosols and air conditioners. Pediatr
Infect Dis J. 1998 Aug;17(8):716-22.
Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by
generations of beta-lactam antibiotics. Clin Infect Dis. 1997 Jan;24 Suppl
1:S19-45.
Mehall JR, Kite CA, Gilliam CH, Jackson RJ, Smith SD. Enteral feeding tubes are a
reservoir for nosocomial antibiotic-resistant pathogens. J Pediatr Surg. 2002
Jul;37(7):1011-2.
Meremikwu MM, Nwachukwu CE, Asuquo AE, Okebe JU, Utsalo SJ. Bacterial
isolates from blood cultures of children with suspected septicaemia in Calabar,
Nigeria.BMC Infect Dis. 2005 Dec 8;5:110.
Miranda G, Castro N, Leaños B, Valenzuela A, Garza-Ramos U, Rojas T, Solórzano
F, Chihu L, Silva J. Clonal and horizontal dissemination of Klebsiella
pneumonia expressing SHV-5 extended-spectrum beta-lactamase in a Mexican
pediatric hospital. J Clin Microbiol. 2004 Jan;42(1):30-5
Miranda G, Castro N, Leaños B, Valenzuela A, Garza-Ramos U, Rojas T, Solórzano
F, Chihu L, Silva J. Clonal and horizontal dissemination of Klebsiella
pneumonia expressing SHV-5 extended-spectrum beta-lactamase in a Mexican
pediatric hospital. J Clin Microbiol. 2004 Jan;42(1):30-5.
Miriagou V, Tzouvelekis LS, Villa L, Lebessi E, Vatopoulos AC, Carattoli A,
Tzelepi E. CMY-13, a novel inducible cephalosporinase encoded by an
Escherichia coli plasmid. Antimicrob Agents Chemother. 2004
Aug;48(8):3172-4.
Mitsuhashi, S., and M. Inoue. Mechanisms of resistance to betalactam antibiotics, S.
Mitsuhashi (ed.), Springer-Verlag, New York: 1981.
Moissenet D, Salauze B, Clermont O, Bingen E, Arlet G, Denamur E, Mérens A,
Mitanchez D, Vu-Thien H. Meningitis caused by Escherichia coli producing
TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a
neonatal ward:epidemiological investigation and characterization of the strain.
J Clin Microbiol. 2010 Jul;48(7):2459-63.
Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of
newer beta-lactamases in gram-negative clinical isolates collected in the
United States from 2001 to 2002. J Clin Microbiol. 2006 Sep;44(9):3318-24.
160
Moland ES, Sanders CC, Thomson KS. Can results obtained with commercially
available MicroScan microdilution panels serve as an indicator of beta-
lactamase production among escherichia coli and Klebsiella isolates with
hidden resistance to expanded-spectrum cephalosporins and aztreonam? J Clin
Microbiol. 1998 Sep;36(9):2575-9.
Monga K, Fernandez A, Deodhar L. Changing bacteriological patterns in neonatal
septicaemia. Indian J Pediatr. 1986 Jul-Aug;53(4):505-8
Monif GR. Maternal risk factors for perinatal septicemia due to the
Enterobacteriaceae. Am J Perinatol. 2000;17(1):19-22.
Moolenaar RL, Crutcher JM, San Joaquin VH, Sewell LV, Hutwagner LC, Carson
LA, Robison DA, Smithee LM, Jarvis WR. A prolonged outbreak of
Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails
play a role in disease transmission? Infect Control Hosp Epidemiol. 2000
Feb;21(2):80-5
Moreno MT, Vargas S, Poveda R, Sáez-Llorens X. Neonatal sepsis and meningitis in
a developing Latin American country. Pediatr Infect Dis J. 1994
Jun;13(6):516-20.
Mugalu J, Nakakeeto MK, Kiguli S, Kaddu-Mulindwa DH. Aetiology, risk factors
and immediate outcome of bacteriologically confirmed neonatal septicaemia in
Mulago hospital, Uganda. Afr Health Sci. 2006 Jun;6(2):120-6.
Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, Paton S.
Molecular characterization of cefoxitin-resistant Escherichia coli from
Canadian hospitals. Antimicrob Agents Chemother. 2005 Jan;49(1):358-65.
Mussi-Pinhata MM, Nobre RA, Martinez FE, Jorge SM, Ferlin ML, Gonçalves
AL.Early-onset bacterial infection in Brazilian neonates with respiratory
distress: a hospital-based study. J Trop Pediatr. 2004 Feb;50(1):6-11.
Nadjar D, Rouveau M, Verdet C, Donay L, Herrmann J, Lagrange PH, Philippon A,
Arlet G. Outbreak of Klebsiella pneumoniae producing transferable AmpC-
type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol
Lett. 2000 Jun 1;187(1):35-40.
Naik Jigna. Phenotypic and Molecular Detection of CTX-M ESBL Produced by
Clinical Isolates of E.coli- an imerging Cephalosporin Resistant Threat [PhD
thesis]. India, Gujarat: Veer Narmad South Gujarat University; 2012.
Nakano R, Okamoto R, Nakano Y, Kaneko K, Okitsu N, Hosaka Y, Inoue M. CFE-
1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene
originating from Citrobacter freundii. Antimicrob Agents Chemother. 2004
Apr;48(4):1151-8.
Nambiar S, Singh N. Change in epidemiology of health care-associated infections in
a neonatal intensive care unit. Pediatr Infect Dis J. 2002 Sep;21(9):839-42.
161
Nasa P, Juneja D, Singh O, Dang R, Singh A. An observational study on
bloodstream extended-spectrum beta-lactamase infection in critical care unit:
incidence, risk factors and its impact on outcome. Eur J Intern Med. 2012
Mar;23(2):192-5.
Nasim K, Elsayed S, Pitout JD, Conly J, Church DL, Gregson DB. New method for
laboratory detection of AmpC beta-lactamases in Escherichia coli and
Klebsiella pneumoniae. J Clin Microbiol. 2004 Oct;42(10):4799-802.
National Committee for Clinical Laboratory Standards. 2005. Performance standards
for antimicrobial susceptibility testing; 15th informational supplement (M100-
S15). National Committee for Clinical Laboratory Standards, Wayne, Pa.
Naumovski L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, Graves D,
Palzkill T, Arvin AM. Outbreak of ceftazidime resistance due to a novel
extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob
Agents Chemother. 1992 Sep;36(9):1991-6. Erratum in: Antimicrob Agents
Chemother 1993 Feb;37(2):375.
Neonatal morbidity and mortality: report of the National Neonatal-Perinatal
Database. Indian Pediatr. 1997 Nov;34(11):1039-42
Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP.
Antibiotic resistance among gram-negative bacilli in US intensive care units:
implications for fluoroquinolone use. JAMA. 2003 Feb 19;289(7):885-8
Newby J. Nosocomial infection in neonates: inevitable or preventable? J Perinat
Neonatal Nurs. 2008 Jul-Sep;22(3):221-7.
Nikaido H, Liu W, Rosenberg EY. Outer membrane permeability and beta-lactamase
stability of dipolar ionic cephalosporins containing methoxyimino substituents.
Antimicrob Agents Chemother. 1990 Feb;34(2):337-42.
Noel GJ, Laufer DA, Edelson PJ. Anaerobic bacteremia in a neonatal intensive care
unit: an eighteen-year experience. Pediatr Infect Dis J. 1988 Dec;7(12):858-62
Nordmann P, Naas T. Sequence analysis of PER-1 extended-spectrum beta-
lactamase from Pseudomonas aeruginosa and comparison with class A beta-
lactamases. Antimicrob Agents Chemother. 1994 Jan;38(1):104-14.
Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM
carbapenemases. Trends Microbiol. 2011 Dec;19(12):588-95.
Nordström K, Burman LG, Eriksson-Grennberg KG. Resistance of Escherichia coli
to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J
Bacteriol. 1970 Mar;101(3):659-68.
Nyhan WL, Fousek MD. Septicemia of the newborn. Pediatrics. 1958
Aug;22(2):268-78.
162
Olsson O, Bergström S, Normark S. Identification of a novel ampC beta-lactamase
promoter in a clinical isolate of Escherichia coli. EMBO J.1982;1(11):1411-6.
Oteo J, Cercenado E, Fernández-Romero S, Saéz D, Padilla B, Zamora E, Cuevas O,
Bautista V, Campos J. Extended-spectrum-β-lactamase-producing Escherichia
coli as a cause of pediatric infections: report of a neonatal intensive care unit
outbreak due to a CTX-M-14-producing strain. Antimicrob Agents Chemother.
2012 Jan;56(1):54-8.
Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe
KW.Epidemiology and clinical features of bloodstream infections caused by
AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob
Agents Chemother. 2004 Oct;48(10):3720-8.
Pai H, Kim J, Kim J, Lee JH, Choe KW, Gotoh N. Carbapenem resistance
mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents
Chemother. 2001 Feb;45(2):480-4.
Pai H, Kim J, Kim J, Lee JH, Choe KW, Gotoh N. Carbapenem resistance
Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-
lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy
beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents
Chemother. 1990 Nov;34(11):2200-9.
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr,
Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH,
Walsh TJ, Sobel JD; Infectious Diseases Society of America. Clinical practice
guidelines for the management of candidiasis: 2009 update by the Infectious
Diseases Society of America. Clin Infect Dis. 2009 Mar 1;48(5):503-35.
Parveen M, Mandal J, Sangeetha V, Ganesan V, Preethi V, Harish BN, Srinivasan S,
Parija SC. Third-generation cephalosporin-resistant Vibrio cholerae, India.
Emerg Infect Dis. 2012 Aug;18(8):1326-8.
Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive screening tests
for suspected class A carbapenemase production in species of
Enterobacteriaceae. J Clin Microbiol. 2009 Jun;47(6):1631-9.
Pasteran F, Mendez T, Rapoport M, Guerriero L, Corso A. Controlling
Pasteran FG, Otaegui L, Guerriero L, Radice G, Maggiora R, Rapoport M, Faccone
D, Di Martino A, Galas M. Klebsiella pneumoniae Carbapenemase-2, Buenos
Aires,Argentina. Emerg Infect Dis. 2008 Jul;14(7):1178-80.
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update.
Clin Microbiol Rev. 2005 Oct;18(4):657-86.
Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP,
Bonomo RA, Rice LB, McCormack JG, Yu VL. Outcome of cephalosporin
163
treatment for serious infections due to apparently susceptible organisms
producing extended-spectrum beta-lactamases: implications for the clinical
microbiology laboratory. J Clin Microbiol. 2001 Jun;39(6):2206-12.
Patterson JE. Extended spectrum beta-lactamases: a therapeutic dilemma. Pediatr
Infect Dis J. 2002 Oct;21(10):957-9.
Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase
genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002
Jun;40(6):2153-62.
Perlman JM. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral
palsy: medicolegal issues. Pediatrics. 1997 Jun;99(6):851-9.
Perlman JM. Summary proceedings from the neurology group on hypoxic-ischemic
encephalopathy. Pediatrics. 2006 Mar;117(3 Pt 2):S28-33.
Perry JD, Naqvi SH, Mirza IA, Alizai SA, Hussain A, Ghirardi S, Orenga
S,Wilkinson K, Woodford N, Zhang J, Livermore DM, Abbasi SA, Raza MW.
Prevalence of faecal carriage of Enterobacteriaceae with NDM-1
carbapenemase at military hospitals in Pakistan, and evaluation of two
chromogenic media. J Antimicrob Chemother. 2011 Oct;66(10):2288-94.
Pessoa-Silva CL, Meurer Moreira B, Câmara Almeida V, Flannery B, Almeida Lins
MC, Mello Sampaio JL, Martins Teixeira L, Vaz Miranda LE, Riley LW,
Gerberding JL. Extended-spectrum beta-lactamase-producing Klebsiella
pneumoniae in a neonatal intensive care unit: risk factors for infection and
colonization. J Hosp Infect. 2003 Mar;53(3):198-206
Petit A, Ben-Yaghlane-Bouslama H, Sofer L, Labia R. Characterization of
chromosomally encoded penicillinases in clinical isolates of Klebsiella
pneumoniae. J Antimicrob Chemother. 1992 Jun;29(6):629-38.
Petroni A, Corso A, Melano R, Cacace ML, Bru AM, Rossi A, Galas M. Plasmidic
extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in
Argentina. Antimicrob Agents Chemother. 2002 May;46(5):1462-8.
Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type beta-lactamases.
Antimicrob Agents Chemother. 2002 Jan;46(1):1-11.
Philippon A, Labia R, Jacoby G. Extended-spectrum beta-lactamases. Antimicrob
Agents Chemother. 1989 Aug;33(8):1131-6. Review. PubMed PMID: 2679367
Phillips SE, Bradley JS. Bacteremia detected by lysis direct plating in a neonatal
intensive care unit. J Clin Microbiol. 1990 Jan;28(1):1-4.
Pinto-Tomás AA, Anderson MA, Suen G, Stevenson DM, Chu FS, Cleland WW,
Weimer PJ, Currie CR. Symbiotic nitrogen fixation in the fungus gardens of
leaf-cutter ants. Science. 2009 Nov 20;326(5956):1120-3.
164
Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing
Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis.
2008 Mar;8(3):159-66. doi: 10.1016/S1473-3099(08)70041-0.
Pittet D, Donaldson L. Clean Care is Safer Care: a worldwide priority. Lancet. 2005
Oct 8;366(9493):1246-7
Pittet D, Simon A, Hugonnet S, Pessoa-Silva CL, Sauvan V, Perneger TV. Hand
hygiene among physicians: performance, beliefs, and perceptions. Ann Intern
Med. 2004 Jul 6;141(1):1-8.
Pittet D. Improving adherence to hand hygiene practice: a multidisciplinary
approach. Emerg Infect Dis. 2001 Mar-Apr;7(2):234-40.
Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-
hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its
structurally related beta-lactamase CTX-M-3. J Antimicrob Chemother. 2002
Dec;50(6):1031-4.
Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. Biochemical sequence
analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the
class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents
Chemother. 2000 Mar;44(3):622-32.
Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and
biochemical characterization of VEB-1, a novel class A extended-spectrum
beta-lactamase encoded by an Escherichia coli integron gene. Antimicrob
Agents Chemother. 1999 Mar;43(3):573-81.
Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P.
Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase
and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa
clinicalisolate in France. Antimicrob Agents Chemother. 2000 Apr;44(4):891-
7.
Poirel L, Weldhagen GF, Naas T, De Champs C, Dove MG, Nordmann P. GES-2, a
class A beta-lactamase from Pseudomonas aeruginosa with increased
hydrolysis of imipenem. Antimicrob Agents Chemother. 2001 Sep;45(9):2598-
603.
Polin RA; Committee on Fetus and Newborn. Management of neonates with
suspected or proven early-onset bacterial sepsis. Pediatrics. 2012
May;129(5):1006-15.
Polin Richard A.,Lisa Saiman. Nosocomial Infections in the Neonatal Intensive Care
Unit. Reviews Vol.4 March(3) 2003.
Popowski T, Goffinet F, Maillard F, Schmitz T, Leroy S, Kayem G. Maternal
markers for detecting early-onset neonatal infection and chorioamnionitis in
165
cases of premature rupture of membranes at or after 34 weeks of gestation: a
two-center prospective study. BMC Pregnancy Childbirth. 2011 Apr 7;11:26.
Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect
Dis. 2008 Jan;8(1):19-31.
Pouillot R, Hoelzer K, Jackson KA, Henao OL, Silk BJ. Relative risk of listeriosis in
Foodborne Diseases Active Surveillance Network (FoodNet) sites according to
age, pregnancy, and ethnicity. Clin Infect Dis. 2012 Jun;54 Suppl 5:S405-10.
Power P, Galleni M, Ayala JA, Gutkind G. Biochemical and molecular
characterization of three new variants of AmpC beta-lactamases from
Morganella morganii. Antimicrob Agents Chemother. 2006 Mar;50(3):962-7.
Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and beta-
lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-
producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested
by using NCCLS ESBL methodology. J Clin Microbiol. 2004 Jan;42(1):269-
75.
Queenan AM, Jenkins S, Bush K. Cloning and biochemical characterization of FOX-
5, an AmpC-type plasmid-encoded beta-lactamase from a New York City
Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother. 2001
Nov;45(11):3189-94.
Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-
lactamase (TEM-10) conferring selective resistance to ceftazidime and
aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents
Chemother. 1989 Sep;33(9):1451-6.
Rahman MM, Haq JA, Hossain MA, Sultana R, Islam F, Islam AH. Prevalence of
extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella
pneumoniae in an urban hospital in Dhaka, Bangladesh. Int J Antimicrob
Agents. 2004 Nov;24(5):508-10.
Rajaratnam JK, Marcus JR, Flaxman AD, Wang H, Levin-Rector A, Dwyer L, Costa
M, Lopez AD, Murray CJ. Neonatal, postneonatal, childhood, and under-5
mortality for 187 countries, 1970-2010: a systematic analysis of progress
towards Millennium Development Goal 4. Lancet. 2010 Jun
5;375(9730):1988-2008.
Ratna AK, Menon I, Kapur I, Kulkarni R. Occurrence & detection of AmpC beta-
lactamases at a referral hospital in Karnataka. Indian J Med Res. 2003
Jul;118:29-32.
Recchia GD, Hall RM. Gene cassettes: a new class of mobile element. Microbiology.
1995 Dec;141 ( Pt 12):3015-27.
166
Recommendations for preventing the spread of vancomycin resistance. hospital
infection control practices advisory committee (HICPAC). Infect Control Hosp
Epidemiol. 1995;16:105-113
Richmond MH, Sykes RB. The beta-lactamases of gram-negative bacteria and their
possible physiological role. Adv Microb Physiol. 1973;9:31-88.
Robin F, Delmas J, Archambaud M, Schweitzer C, Chanal C, Bonnet R. CMT-type
beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-
lactamase detection. Antimicrob Agents Chemother. 2006 Jul;50(7):2403-8.
Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, Mehta A. Detection
of -lactamases in nosocomial gram negative clinical isolates. Indian J Med
Microbiol. 2004 Oct-Dec;22(4):247-50
Rogers MB, Parker AC, Smith CJ. Cloning and characterization of the endogenous
cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup
of Ambler class A beta-lactamases. Antimicrob Agents Chemother. 1993
Nov;37(11):2391-400.
Roy I, Jain A, Kumar M, Agarwal SK. Bacteriology of neonatal septicaemia in a
tertiary care hospital of northern India. Indian J Med Microbiol. 2002 Jul-
Sep;20(3):156-9.
Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing
Enterobacteriaceae: considerations for diagnosis, prevention and drug
treatment. Drugs. 2003;63(4):353-65.
Ruppé E, Bidet P, Verdet C, Arlet G, Bingen E. First detection of the Ambler class C
1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk
synergy test. J Clin Microbiol. 2006 Nov;44(11):4204-7.
Sanders CC, Thomson KS, Bradford PA. Problems with detection of beta-lactam
resistance among nonfastidious gram-negative bacilli. Infect Dis Clin North
Am. 1993 Jun;7(2):411-24.
Sankar S, Narayanan H, Kuppanan S, Nandagopal B. Frequency of extended-
spectrum β-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed
multi-specialty hospital in Vellore district, Tamil Nadu, India. Infection. 2012
Aug;40(4):425-9.
Sasirekha B, Shivakumar S. Occurrence of Plasmid-Mediated AmpC β-Lactamases
Among Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a
Tertiary Care Hospital in Bangalore. Indian J Microbiol. 2012 Jun;52(2):174-
9.
Sawai T, Mitsuhashi S, Yamagishi S. Drug resistance of enteric bacteria. XIV.
Comparison of beta-lactamases in gram-negative rod bacteria resistant to
alpha-aminobenzylpenicillin. Jpn J Microbiol. 1968 Dec;12(4):423-34
167
Schmidtke AJ, Hanson ND. Role of ampD homologs in overproduction of AmpC in
clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother.
2008 Nov;52(11):3922-7.
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B
streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep.
2002 Aug 16;51(RR-11):1-22
Schrag SJ, Stoll BJ. Early-onset neonatal sepsis in the era of widespread intrapartum
chemoprophylaxis. Pediatr Infect Dis J. 2006 Oct;25(10):939-40.
Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB,
Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease
in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000 Jan
6;342(1):15-20.
Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan
MJ,Patel D, Peters MT, Stoll B, Levine OS. Risk factors and opportunities for
prevention of early-onset neonatal sepsis: a multicenter case-control study.
Pediatrics. 2000 Jan;105(1 Pt 1):21-6
Schuchat A. Epidemiology of group B streptococcal disease in the United States:
shifting paradigms. Clin Microbiol Rev. 1998 Jul;11(3):497-513.
Schulz-Stübner S, Kniehl E. Transmission of extended-spectrum β-lactamase
Klebsiella oxytoca via the breathing circuit of a transport ventilator: root cause
analysis and infection control recommendations. Infect Control Hosp
Epidemiol. 2011 Aug;32(8):828-9.
Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with
extended-spectrum beta-lactamase production in Enterobacteriaceae
bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother.
2007 Nov;60(5):913-20.
Segal H, Nelson EC, Elisha BG. Genetic environment and transcription of ampC in
an Acinetobacter baumannii clinical isolate. Antimicrob Agents Chemother.
2004 Feb;48(2):612-4.
Shah AJ, Mulla SA, Revdiwala SB. Neonatal sepsis: high antibiotic resistance of the
bacterial pathogens in a neonatal intensive care unit of a tertiary care hospital.
J Clin Neonatol. 2012 Apr;1(2):72-5.
Shah Manisha. Study of Prevelence and Antibiotic Resistant Pettern in Cases of
Neonatal Septicemia. [M.Phil. Dissertation]. India, Gujarat: Veer Narmad
South Gujarat University; 2010
Shahid M, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended-
spectrum and AmpC beta-lactamases by a new spot-inoculation method and
modified three-dimensional extract test: comparison with the conventional
168
three-dimensional extract test. J Antimicrob Chemother. 2004 Sep;54(3):684-
7.
Shakil S, Khan AU. Infected foot ulcers in male and female diabetic patients: a
clinico-bioinformative study. Ann Clin Microbiol Antimicrob. 2010 Jan
14;9:2.
Sharma M, Goel N, Chaudhary U, Aggarwal R, Arora DR. Bacteraemia in children.
Indian J Pediatr. 2002 Dec;69(12):1029-32.
Sharma PP, Halder D, Dutta AK, Dutta R, Bhatnagar S, Bali A, Kumari
S.Bacteriological profile of neonatal septicemia. Indian Pediatr. 1987
Nov;24(11):1011-7
Sheth Kaushal , Patel Tejas, Malek Saklainhaider and Tripathi1 CB. Antibiotic
Sensitivity Pattern of Bacterial Isolates from the Intensive Care Unit of a
Tertiary Care Hospital in India. Trop J Pharm Res, December 11 (6): 991.
2012
Shrestha S, Adhikari N, Rai BK, Shreepaili A. Antibiotic resistance pattern of
bacterial isolates in neonatal care unit. JNMA J Nepal Med Assoc. 2010 Oct-
Dec;50(180):277-81
Siegel JD, McCracken GH Jr. Sepsis neonatorum. N Engl J Med. 1981 Mar
12;304(11):642-7.
Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control
Practices Advisory Committee. 2007 Guideline for Isolation Precautions:
Preventing Transmission of Infectious Agents in Health Care Settings. Am J
Infect Control. 2007 Dec;35(10 Suppl 2):S65-164
Siegrist CA, Barrios C, Martinez X, Brandt C, Berney M, Córdova M, Kovarik J,
Lambert PH. Influence of maternal antibodies on vaccine responses: inhibition
of antibody but not T cell responses allows successful early prime-boost
strategies in mice. Eur J Immunol. 1998 Dec;28(12):4138-48.
Siegrist CA, Córdova M, Brandt C, Barrios C, Berney M, Tougne C, Kovarik J,
Lambert PH. Determinants of infant responses to vaccines in presence of
maternal antibodies. Vaccine. 1998 Aug-Sep;16(14-15):1409-14.
Silk BJ, Date KA, Jackson KA, Pouillot R, Holt KG, Graves LM, Ong KL, Hurd S,
Meyer R, Marcus R, Shiferaw B, Norton DM, Medus C, Zansky SM,
Cronquist AB, Henao OL, Jones TF, Vugia DJ, Farley MM, Mahon BE.
Invasive listeriosis in the Foodborne Diseases Active Surveillance Network
(FoodNet), 2004-2009: further targeted prevention needed for higher-risk
groups. Clin Infect Dis. 2012 Jun;54 Suppl 5:S396-404.
Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, Cal RG,
de Sousa EF, Abe TP, de Andrade J, de Matos JD, Rezende E, Assunção M,
169
Avezum A, Rocha PC, de Matos GF, Bento AM, Corrêa AD, Vieira PC,
Knobel E; Brazilian Sepsis Epidemiological Study. Brazilian Sepsis
Epidemiological Study (BASES study). Crit Care. 2004 Aug;8(4):R251-60.
Silva J, Aguilar C, Ayala G, Estrada MA, Garza-Ramos U, Lara-Lemus R, Ledezma
L. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from
Escherichia coli. Antimicrob Agents Chemother. 2000 Apr;44(4):997-1003.
Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, Rattan A.
Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A,Perroux R,
Cluzel R. Transferable resistance to third-generation cephalosporins in clinical
isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-
lactamase. J Antimicrob Chemother. 1987 Sep;20(3):323-34
Sivanandan S, Soraisham AS, Swarnam K. Choice and duration of antimicrobial
therapy for neonatal sepsis and meningitis. Int J Pediatr. 2011;2011:712150.
doi:10.1155/2011/712150. Epub 2011 Nov 20.
Slagle TA, Bifano EM, Wolf JW, Gross SJ. Routine endotracheal cultures for the
prediction of sepsis in ventilated babies. Arch Dis Child. 1989 Jan;64(1 Spec
No):34-8.
Smith CJ, Bennett TK, Parker AC. Molecular and genetic analysis of the Bacteroides
uniformis cephalosporinase gene, cblA, encoding the species-specific beta-
lactamase. Antimicrob Agents Chemother. 1994 Aug;38(8):1711-5.
Sohn AH, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover
BH,Siegel JD, Jarvis WR; Pediatric Prevention Network. Prevalence of
nosocomial infections in neonatal intensive care unit patients: Results from the
first national point-prevalence survey. J Pediatr. 2001 Dec;139(6):821-7
Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, Lee KM. Use of boronic
acid disk methods to detect the combined expression of plasmid-mediated
AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical
isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn
Microbiol Infect Dis. 2007 Mar;57(3):315-8.
Srivastava S, Sen MR, Kumar A, Anupurba S. Neonatal listeriosis. Indian J Pediatr.
2005 Dec;72(12):1059-60
Steer P. The epidemiology of preterm labour. BJOG. 2005 Mar;112 Suppl 1:1-3.
Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ,
Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC.
Characterization of clinical isolates of Klebsiella pneumoniae from 19
laboratories using the National Committee for Clinical Laboratory Standards
extended-spectrum beta-lactamase detection methods. J Clin Microbiol. 2001
Aug;39(8):2864-72.
170
Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ,
Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC.
Characterization of clinical isolates of Klebsiella pneumoniae from 19
laboratories using the National Committee for Clinical Laboratory Standards
extended-spectrum beta-lactamase detection methods. J Clin Microbiol. 2001
Aug;39(8):2864-72.
Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, Fanaroff AA,
Lemons JA, Donovan EF, Oh W, Stevenson DK, Ehrenkranz RA, Papile LA,
Verter J, Wright LL. Late-onset sepsis in very low birth weight neonates: a
report from the National Institute of Child Health and Human Development
Neonatal Research Network. J Pediatr. 1996 Jul;129(1):63-71.
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons
JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB,
Shankaran S,Laptook AR, Stevenson DK, Papile LA, Poole WK. Changes in
pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl
J Med. 2002 Jul 25;347(4):240-7
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons
JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB,
Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Late-onset
sepsis in very low birth weight neonates: the experience of the NICHD
Neonatal Research Network. Pediatrics. 2002 Aug;110(2 Pt 1):285-91
Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins
RD; National Institute of Child Health and Human Development Neonatal
Research Network. Neurodevelopmental and growth impairment among
extremely low-birth-weight infants with neonatal infection. JAMA. 2004 Nov
17;292(19):2357-65.
Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A,
Walsh M, Oh W, Hale E; National Institute of Child Health and Human
Development. Very low birth weight preterm infants with early onset neonatal
sepsis: the predominance of gram-negative infections continues in the National
Institute of Child Health and Human Development Neonatal Research
Network, 2002-2003. Pediatr Infect Dis J. 2005 Jul;24(7):635-9.
Stoll BJ. Infections of the neonatal infant. 18th
ed. Philadelphia: Saunders Elsevier:
2007.
Stürenburg E, Kühn A, Mack D, Laufs R. A novel extended-spectrum beta-lactamase
CTX-M-23 with a P167T substitution in the active-site omega loop associated
with ceftazidime resistance. J Antimicrob Chemother. 2004 Aug;54(2):406-9.
Epub 2004 Jun 16.
Subha A, Devi VR, Ananthan S. AmpC beta-lactamase producing multidrug resistant
strains of Klebsiella spp. & Escherichia coli isolated from children under five
in Chennai. Indian J Med Res. 2003 Jan;117:13-8.
171
Sundaram V, Kumar P, Dutta S, Mukhopadhyay K, Ray P, Gautam V, Narang A.
Blood culture confirmed bacterial sepsis in neonates in a North Indian tertiary
care center: changes over the last decade. Jpn J Infect Dis. 2009 Jan;62(1):46-
50
Sykes RB, Matthew M. The beta-lactamases of gram-negative bacteria and their role
in resistance to beta-lactam antibiotics. J Antimicrob Chemother. 1976
Jun;2(2):115-57.
Tallur SS, Kasturi AV, Nadgir SD, Krishna BV. Clinico-bacteriological study of
neonatal septicemia in Hubli. Indian J Pediatr. 2000 Mar;67(3):169-74.
Tamelien÷ R, Barčait÷ E, Stonien÷ D, Buinauskien÷ J, Markūnien÷ E,Kudrevičien÷
A, Vitkauskien÷ A, Jomantien÷ D, Nadišauskien÷ R. Escherichia coli
colonization in neonates: prevalence, perinatal transmission, antimicrobial
susceptibility, and risk factors. Medicina (Kaunas). 2012;48(2):71-6.
Tan TY, Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect
plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and
Proteus mirabilis. Antimicrob Agents Chemother. 2009 Jan;53(1):146-9.
Tan TY, Ng SY, Teo L, Koh Y, Teok CH. Detection of plasmid-mediated AmpC in
Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. J Clin Pathol.
2008 May;61(5):642-4.
Taneja N, Rao P, Arora J, Dogra A. Occurrence of ESBL & Amp-C beta-lactamases
& susceptibility to newer antimicrobial agents in complicated UTI. Indian J
Med Res. 2008 Jan;127(1):85-8.
Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF. Detection and reporting of
organisms producing extended-spectrum beta-lactamases: survey of
laboratories in Connecticut. J Clin Microbiol. 1999 Dec;37(12):4065-70.
Then RL, Angehrn P. Trapping of nonhydrolyzable cephalosporins by
cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a
possible resistance mechanism. Antimicrob Agents Chemother. 1982
May;21(5):711-7.
Thomson KS, Sanders CC. A simple and reliable method to screen isolates of
Escherichia coli and Klebsiella pneumoniae for the production of TEM- and
SHV-derived extended-spectrum beta-lactamases. Clin Microbiol Infect.
1997;3(5):549-554.
Thomson KS, Sanders CC. Detection of extended-spectrum beta-lactamases in
members of the family Enterobacteriaceae: comparison of the double-disk and
three-dimensional tests. Antimicrob Agents Chemother. 1992 Sep;36(9):1877-
82.
172
Thomson KS, Smith Moland E. Version 2000: the new beta-lactamases of Gram-
negative bacteria at the dawn of the new millennium. Microbes Infect. 2000
Aug;2(10):1225-35.
Thomson KS. Controversies about extended-spectrum and AmpC beta-
lactamases.Emerg Infect Dis. 2001 Mar-Apr;7(2):333-6.
Tiraboschi IC, Niveyro C, Mandarano AM, Messer SA, Bogdanowicz E, Kurlat I,
Lasala MB. Congenital candidiasis: confirmation of mother-neonate
transmission using molecular analysis techniques. Med Mycol. 2010
Feb;48(1):177-81.
Toledano H, Schlesinger Y, Raveh D, Rudensky B, Attias D, Eidelman AI, Yinnon
AM. Prospective surveillance of vancomycin-resistant enterococci in a
neonatal intensive care unit. Eur J Clin Microbiol Infect Dis. 2000
Apr;19(4):282-7.
Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, Simor
AE,Paton S, Mulvey MR; Canadian Nosocomial Infection Surveillance
Program. ampC gene expression in promoter mutants of cefoxitin-resistant
Escherichia coli clinical isolates. FEMS Microbiol Lett. 2007 May;270(2):265-
71.
Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PC, Gerards LJ, Adriaanse AH,
van Lingen RA, Kollée LA. Epidemiology of neonatal group B streptococcal
disease in the Netherlands before and after introduction of guidelines for
prevention. Arch Dis Child Fetal Neonatal Ed. 2007 Jul;92(4):F271-6.
Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S. First
occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital
and recommendation for detection with boronic acid disc tests. J Antimicrob
Chemother. 2008 Dec;62(6):1257-60.
Tschudin-Sutter S, Frei R, Battegay M, Hoesli I, Widmer AF. Extended spectrum ß-
lactamase-producing Escherichia coli in neonatal care unit. Emerg Infect
Dis.2010 Nov;16(11):1758-60.
Tucker J; UK Neonatal Staffing Study Group. Patient volume, staffing, and
workload in relation to risk-adjusted outcomes in a random stratified sample of
UK neonatal intensive care units: a prospective evaluation. Lancet. 2002 Jan
12;359(9301):99-107.
Ullah A, Barman A, Haque J, Khanum M, Bari I. Birthweight and early neonatal
health: Bangladesh perspective. Paediatr Perinat Epidemiol. 2009
Nov;23(6):542-7.
UNICEF, WHO, World Bank, UN Population Division. Levels and trends in child
mortality. 2012.
173
Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, Kocazeybek
B,Tatman-Otkun M, Leblebicioglu H, Ozinel MA, Akalin H, Kocagoz S,
Korten V.Clinical importance of extended-spectrum beta-lactamase (PER-1-
type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J
Med Microbiol. 2001 Jul;50(7):642-5
Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, Kocazeybek
B,Tatman-Otkun M, Leblebicioglu H, Ozinel MA, Akalin H, Kocagoz S,
Korten V.Clinical importance of extended-spectrum beta-lactamase (PER-1-
type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J
Med Microbiol. 2001 Jul;50(7):642-5.
Vahaboglu H, Hall LM, Mulazimoglu L, Dodanli S, Yildirim I, Livermore
DM.Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-
lactamase,in Salmonella typhimurium from Istanbul, Turkey. J Med Microbiol.
1995 Oct;43(4):294-9.
Vahaboglu H, Oztürk R, Aygün G, Coşkunkan F, Yaman A, Kaygusuz
A,Leblebicioglu H, Balik I, Aydin K, Otkun M. Widespread detection of PER-
1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter
and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter
study. Antimicrob Agents Chemother. 1997 Oct;41(10):2265-9. Erratum in:
Antimicrob Agents Chemother 1998 Feb;42(2):484.
Vahaboglu H, Saribaş S, Akbal H, Ozturk R, Yucel A. Activities of cefepime and
five other antibiotics against nosocomial PER-1-type and/or OXA-10-type
beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. J
Antimicrob Chemother. 1998 Aug;42(2):269-70.
Van der Zwet WC, Kaiser AM, van Elburg RM, Berkhof J, Fetter WP, Parlevliet
GA, Vandenbroucke-Grauls CM. Nosocomial infections in a Dutch neonatal
intensive care unit: surveillance study with definitions for infectio specifically
adapted for neonates. J Hosp Infect. 2005 Dec;61(4):300-11
Verboon-Maciolek MA, Thijsen SF, Hemels MA, Menses M, van Loon AM, Krediet
TG,Gerards LJ, Fleer A, Voorbij HA, Rijkers GT. Inflammatory mediators for
the diagnosis and treatment of sepsis in early infancy. Pediatr Res. 2006
Mar;59(3):457-61.
Verdet C, Arlet G, Barnaud G, Lagrange PH, Philippon A. A novel integron in
Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its
regulator gene ampR, originated from Morganella morganii. Antimicrob
Agents Chemother. 2000 Jan;44(1):222-5.
Villari P, Iacuzio L, Torre I, Scarcella A. Molecular epidemiology as an effective
tool in the surveillance of infections in the neonatal intensive care unit. J
Infect. 1998 Nov;37(3):274-81.
174
Voelz A, Müller A, Gillen J, Le C, Dresbach T, Engelhart S, Exner M, Bates CJ,
Simon A. Outbreaks of Serratia marcescens in neonatal and pediatric intensive
care units: clinical aspects, risk factors and management. Int J Hyg Environ
Health. 2010 Mar;213(2):79-87. doi: 10.
Voss A, Melchers WJ, van den Hurk P, Bergman KA, Verweij PE, Meis
JF.[Fingerprinting with the polymerase chain reaction: confirmation of a
Enterobacter cloacae epidemic in a neonatal intensive care unit]. Immun
Infekt.1994 Dec;22(6):214-7.
Vu H, Nikaido H. Role of beta-lactam hydrolysis in the mechanism of resistance of a
beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum
beta-lactams. Antimicrob Agents Chemother. 1985 Mar;27(3):393-8
Wachino J, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, Arakawa Y. Molecular
characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A
beta-lactamase, GES-4, possessing a single G170S substitution in the omega-
loop. Antimicrob Agents Chemother. 2004 Aug;48(8):2905-10.
Wachino J, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, Arakawa Y. Molecular
characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A
beta-lactamase, GES-4, possessing a single G170S substitution in the omega-
loop. Antimicrob Agents Chemother. 2004 Aug;48(8):2905-10.
Walther-Rasmussen J, Høiby N. Plasmid-borne AmpC beta-lactamases. Can J
Microbiol. 2002 Jun;48(6):479-93.
Wanjari K, Mathur M, Baradkar VP, Kumar S. Congenital tuberculosis with candidal
sepsis in a neonate. Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):289-91
Warren S, Tristram S, Bradbury RS. Maternal and neonatal sepsis caused by
Haemophilus influenzae type d. J Med Microbiol. 2010 Mar;59(Pt 3):370-2.
Warrier I, Du W, Natarajan G, Salari V, Aranda J. Patterns of drug utilization in a
neonatal intensive care unit. J Clin Pharmacol. 2006 Apr;46(4):449-55.
Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrumbeta-
lactamases in Pseudomonas aeruginosa: novel developments and clinical
impact. Antimicrob Agents Chemother. 2003 Aug;47(8):2385-92.
Weng SF, Chao YF, Lin JW. Identification and characteristic analysis of the ampC
gene encoding beta-lactamase from Vibrio fischeri. Biochem Biophys Res
Commun. 2004 Feb 13;314(3):838-43.
Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily
P,Apostol M, Petit S, Farley M, Lynfield R, Reingold A, Hansen NI, Stoll BJ,
Shane AJ, Zell E, Schrag SJ. The burden of invasive early-onset neonatal
sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011
Nov;30(11):937-41.
175
WHO. Perinatal and neonatal mortality for the year 2000: Country, regional and
global estimates. 2006. Geneva, Switzerland, WHO.
Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H. Detection of extended-
spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated
microbiology systems and manual detection procedures. J Clin Microbiol.
2007 Apr;45(4):1167-74.
Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp
EK,Pfaller MA, Doern GV. Animal and human multidrug-
resistant,cephalosporin-resistant salmonella isolates expressing a plasmid-
mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother. 2000
Oct;44(10):2777-83.
Wojsyk-Banaszak I, Szczapa J. [Reliability of polymorphonuclear elastase for the
diagnosis of neonatal sepsis]. Przegl Lek. 2002;59 Suppl 1:43-5. Polish.
World Health organisation. Neonatal and perinatal mortality: country, regional and
global estimates. WHO report 2006. Geneva, World Health Organisation,
2006.
Wu TL, Siu LK, Su LH, Lauderdale TL, Lin FM, Leu HS, Lin TY, Ho M. Outer
membrane protein change combined with co-existing TEM-1 and SHV-1 beta-
lactamases lead to false identification of ESBL-producing Klebsiella
pneumoniae. J Antimicrob Chemother. 2001 Jun;47(6):755-61.
Wynn JL, Benjamin DK Jr, Benjamin DK, Cohen-Wolkowiez M, Clark RH, Smith
PB.Very late onset infections in the neonatal intensive care unit. Early Hum
Dev.2012 Apr;88(4):217-25. doi: 10.1016/j.earlhumdev.2011.08.009.
Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, Shibata N, Kato
H,Shibayama K, Arakawa Y. Practical methods using boronic acid compounds
for identification of class C beta-lactamase-producing Klebsiella pneumoniae
and Escherichia coli. J Clin Microbiol. 2005 Jun;43(6):25518.
Yeung CY, Lee HC, Huang FY, Wang CS. Sepsis during total parenteral nutrition:
exploration of risk factors and determination of the effectiveness of
peripherally inserted central venous catheters. Pediatr Infect Dis J. 1998
Feb;17(2):135-42.
Yong D, Park R, Yum JH, Lee K, Choi EC, Chong Y. Further modification of the
Hodge test to screen AmpC beta-lactamase (CMY-1)-producing strains of
Escherichia coli and Klebsiella pneumoniae. J Microbiol Methods. 2002
Nov;51(3):407-10
Yurdakök M. Antibiotic use in neonatal sepsis. Turk J Pediatr. 1998 Jan-
Mar;40(1):17-33.
176
Zafar N, Wallace CM, Kieffer P, Schroeder P, Schootman M, Hamvas A. Improving
survival of vulnerable infants increases neonatal intensive care unit nosocomial
infection rate. Arch Pediatr Adolesc Med. 2001 Oct;155(10):1098-104.
Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-
acquired neonatal infections in developing countries. Lancet. 2005 Mar 26-Apr
1;365(9465):1175-88.
Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in
newborns and young infants in developing countries. Pediatr Infect Dis J. 2009
Jan;28(1 Suppl):S10-8.
Zárate MS, Gales AC, Picão RC, Pujol GS, Lanza A, Smayevsky J. Outbreak of
OXY-2-Producing Klebsiella oxytoca in a renal transplant unit. J Clin
Microbiol. 2008 Jun;46(6):2099-101.
Zhu LX, Zhang ZW, Liang D, Jiang D, Wang C, Du N, Zhang Q, Mitchelson K,
Cheng J. Multiplex asymmetric PCR-based oligonucleotide microarray for
detection of drug resistance genes containing single mutations in
Enterobacteriaceae. Antimicrob Agents Chemother. 2007 Oct;51(10):3707-13.
177